Chest Medicine
Meta-Analysis: Interventions for the Management of Malignant Pleural Effusions
23 Apr, 2020 | 09:22h | UTC
NIH COVID-19 Treatment Guidelines
22 Apr, 2020 | 09:02h | UTCNIH Coronavirus Disease 2019 (COVID-19) Treatment Guidelines – National Institutes of Health
News Release: Expert U.S. panel develops NIH treatment guidelines for COVID-19
Commentary: New U.S. Treatment Guidelines for Covid-19 Don’t See Much Progress – The New York Times
[Preprint] Observational Study: No Benefit from Hydroxychloroquine in Patients Hospitalized with Covid-19
22 Apr, 2020 | 08:58h | UTCOutcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19 – medRxiv
Commentaries: Study finds no benefit, higher death rate in patients taking hydroxychloroquine for Covid-19 – CNN AND More deaths, no benefit from malaria drug in VA virus study – Associated Press
Evidence Review: Tests for Screening, Diagnosis and Monitoring of COVID-19
22 Apr, 2020 | 08:55h | UTC
Study: SARS-CoV-2 Persists Longer in Stool and in Patients with Severe Disease
22 Apr, 2020 | 08:53h | UTC
Richard Lehman’s Covid-19 Reviews—20 April 2020
22 Apr, 2020 | 08:50h | UTCRichard Lehman’s covid-19 reviews, 20 April 2020 – The BMJ Opinion
“In this weekly round-up, Richard Lehman looks at a personal selection of articles of relevance to clinicians dealing with covid-19”.
Video: Perspectives on the Pandemic | Dr. John Ioannidis Update
21 Apr, 2020 | 08:12h | UTCPerspectives on the Pandemic | Dr. John Ioannidis Update: 4.17.20
Related (from Dr. John Ioannidis): Antibody Tests Suggest that Coronavirus Infections Vastly Exceed Official Counts AND Study: Population-level COVID-19 Mortality Risk
Therapeutic Strategies for Critically Ill Patients with COVID-19
21 Apr, 2020 | 08:14h | UTCTherapeutic strategies for critically ill patients with COVID-19 – Annals of Intensive Care
Opinion – Timed & Titrated use of Steroids in COVID-19?
21 Apr, 2020 | 08:11h | UTCTimed & titrated use of steroid in COVID-19? – PulmCrit
FDA Letter Warns About the Limitations of Antibody Tests for COVID-19
21 Apr, 2020 | 08:08h | UTCCommentary: FDA Warns Providers About Limits of SARS-CoV-2 Antibody Tests – NEJM Journal Watch
D‐dimer Levels on Admission to Predict In‐hospital Mortality in Patients with Covid‐19
21 Apr, 2020 | 08:06h | UTC
Thrombocytopenia and Its Association with Mortality in Patients with COVID‐19
21 Apr, 2020 | 08:04h | UTC
[Preprint] Meta-Analysis: Smoking is Associated with COVID-19 Progression
21 Apr, 2020 | 08:02h | UTCSmoking is Associated with COVID-19 Progression: A Meta-Analysis – medRxiv
Commentary: Smoking doubles risk of severe COVID-19 disease – News Medical
ATS Guideline: Diagnosis and Detection of Sarcoidosis
21 Apr, 2020 | 08:00h | UTCNews Release: First official ATS practice guidelines for Sarcoidosis cover diagnosis and detection – American Thoracic Society
Antibody Tests Suggest that Coronavirus Infections Vastly Exceed Official Counts
20 Apr, 2020 | 00:25h | UTCAntibody tests suggest that coronavirus infections vastly exceed official counts – Nature
See original preprint study: COVID-19 Antibody Seroprevalence in Santa Clara County, California – medRxiv
Author interview: Dr. John Ioannidis Announces Results of COVID-19 Serology Study (video)
Other commentaries: Far more people may have been infected by coronavirus in one California county, study estimates – CNN AND The number of coronavirus infections in Santa Clara, California may be up to 85 times higher than testing shows, according to new research – Business Insider AND Up to 4% of Silicon Valley is already infected with coronavirus – MIT Technology Review
The Promise and Peril of Antibody Testing for COVID-19
20 Apr, 2020 | 00:23h | UTCThe Promise and Peril of Antibody Testing for COVID-19 – JAMA
See also: Will antibody tests for the coronavirus really change everything? – Nature AND Antibody Test, Seen as Key to Reopening Country, Does Not Yet Deliver – The New York Times AND With Broad, Random Tests for Antibodies, Germany Seeks Path out of Lockdown
How Does Coronavirus Kill?
20 Apr, 2020 | 00:21h | UTC
Review: COVID-19 and Thrombotic or Thromboembolic Disease
20 Apr, 2020 | 00:18h | UTC
The Science Underlying COVID-19: Implications for the Cardiovascular System
20 Apr, 2020 | 00:19h | UTCThe Science Underlying COVID-19: Implications for the Cardiovascular System – Circulation
Editorial: COVID-19 Pneumonia: ARDS or Not? – Critical Care
20 Apr, 2020 | 00:09h | UTCEditorial: COVID-19 pneumonia: ARDS or not? – Critical Care
Related: COVID-19 pneumonia: different respiratory treatment for different phenotypes? – Intensive Care Medicine AND Covid-19 Does Not Lead to a “Typical” Acute Respiratory Distress Syndrome – American Journal of Respiratory and Critical Care Medicine
What’s Happening with Remdesivir?
20 Apr, 2020 | 00:12h | UTCWhat’s Happening With Remdesivir? – Science Translational Medicine
See also: Slow down your giddyup on Gilead news – Health News Review
Defining ARDS & Recruitability, with Implications for COVID Treatment
20 Apr, 2020 | 00:06h | UTCDefining ARDS & recruitability, with implications for COVID treatment – PulmCrit
Hospital Preparedness for COVID-19: A Practical Guide from a Critical Care Perspective
20 Apr, 2020 | 00:07h | UTC
Observational Study: Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Seems Safe Among Patients with Hypertension Hospitalized With COVID-19
20 Apr, 2020 | 00:01h | UTC
Systematic Review: Prophylactic Role of Chloroquine and Hydroxychloroquine in COVID‐19
19 Apr, 2020 | 23:57h | UTC